Domain Associates

Founded in 1985, Domain Associates is a venture capital firm with an exclusive focus on life sciences and $2.4 billion of capital under management. Domain’s major investment segments are biotech, medical devices, and diagnostics while additional areas of interest include biomaterials, bioinstrumentation, and specialty pharmaceuticals. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 235 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.


InterWest Partners

For 30 years InterWest Partners has partnered with exceptional entrepreneurs to build winning technology and life sciences companies. With more than 200 years of combined operating and investing experience, InterWest’s team has raised $2.8B, completed more than 70 IPOs, and participated in nearly 60 upside acquisitions. As the firm invests InterWest X, a $650M fund, InterWest continues to believe that providing capital is just the beginning of a long-term collaboration with entrepreneurs to turn their vision into a thriving company.


Blue Ox Healthcare Partners is a private equity investment firm providing capital to growth-stage healthcare companies.  Blue Ox focuses on businesses in the middle market targeting the industry’s transformation to individuality and value-based care in healthcare services, HCIT, and medical and life sciences technologies, whose innovations, strategies and operations are poised for growth.


Catalyst Health Ventures

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the healthcare and life science industries. At the core of its strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Our disciplined investment process leverages both intellectual and financial capital to originate deals, cultivate opportunities and realize the full potential of emerging ventures in the healthcare and life science marketplace.


Chione, Ltd.

Chione Ltd. Is a European investment company, supporting the development of medical diagnostic, pharmaceutical and IT technologies world-wide. Chione is an investor in Karyopharm Therapeutics and Metamark Genetics.


Bill and Melinda gates foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health with vaccines and other life-saving tools and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to significantly improve education so that all young people have the opportunity to reach their full potential. Based in Seattle, Washington, the foundation is led by CEO Dr. Susan Desmond-Hellmann and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.


Osage University Partners

Osage University Partners (OUP) is a venture capital fund that invests exclusively in start-ups that are commercializing university research. Partnered with over 80 universities and research institutions, OUP invests in software, hardware, and life science companies of all stages of company development.  OUP is part of a family of investment funds with Osage Partners, which is based in Philadelphia, PA, and manages in excess of $500 million.


UpStart Life Sciences Capital

UpStart Life Sciences Capital invests in start-up and early-stage healthcare companies. Most of the start-ups are based on breakthrough technologies from major research universities in Utah. The fund focuses on diagnostics, medical devices, drug delivery systems, and biopharma.